259 related articles for article (PubMed ID: 19278606)
1. The metabolic syndrome: insulin resistance.
Mikhail N
Curr Hypertens Rep; 2009 Apr; 11(2):156-8. PubMed ID: 19278606
[TBL] [Abstract][Full Text] [Related]
2. Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.
da Silva AA; do Carmo JM; Li X; Wang Z; Mouton AJ; Hall JE
Can J Cardiol; 2020 May; 36(5):671-682. PubMed ID: 32389340
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance and the sympathetic nervous system.
Egan BM
Curr Hypertens Rep; 2003 Jun; 5(3):247-54. PubMed ID: 12724058
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome, hyperinsulinemia, and cancer.
Hsu IR; Kim SP; Kabir M; Bergman RN
Am J Clin Nutr; 2007 Sep; 86(3):s867-71. PubMed ID: 18265480
[TBL] [Abstract][Full Text] [Related]
5. Perturbed autonomic nervous system function in metabolic syndrome.
Tentolouris N; Argyrakopoulou G; Katsilambros N
Neuromolecular Med; 2008; 10(3):169-78. PubMed ID: 18224460
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance and the metabolic syndrome.
Lann D; Gallagher E; Leroith D
Minerva Med; 2008 Jun; 99(3):253-62. PubMed ID: 18497723
[TBL] [Abstract][Full Text] [Related]
7. [A multidimensional exploration of metabolic syndrome components].
Freitas ED; Haddad JP; Velásquez-Meléndez G
Cad Saude Publica; 2009 May; 25(5):1073-82. PubMed ID: 19488492
[TBL] [Abstract][Full Text] [Related]
8. Metabolic consequences of hyperglycemia and insulin resistance.
Jellinger PS
Clin Cornerstone; 2007; 8 Suppl 7():S30-42. PubMed ID: 18154189
[TBL] [Abstract][Full Text] [Related]
9. The insulin resistance syndrome: physiological considerations.
Kashyap SR; Defronzo RA
Diab Vasc Dis Res; 2007 Mar; 4(1):13-9. PubMed ID: 17469039
[TBL] [Abstract][Full Text] [Related]
10. The association between metabolic syndrome components and the development of atherosclerosis.
Aboonabi A; Meyer RR; Singh I
J Hum Hypertens; 2019 Dec; 33(12):844-855. PubMed ID: 31636352
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and heart failure--the risk, paradox, and treatment.
Gaddam KK; Ventura HO; Lavie CJ
Curr Hypertens Rep; 2011 Apr; 13(2):142-8. PubMed ID: 21298579
[TBL] [Abstract][Full Text] [Related]
12. The use of short-term analysis of heart rate variability to assess autonomic function in obese children and its relationship with metabolic syndrome.
Altuncu ME; Baspinar O; Keskin M
Cardiol J; 2012; 19(5):501-6. PubMed ID: 23042314
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance and sympathetic overactivity in women.
Kaaja RJ; Pöyhönen-Alho MK
J Hypertens; 2006 Jan; 24(1):131-41. PubMed ID: 16331111
[TBL] [Abstract][Full Text] [Related]
14. Cardiometabolic risk management in type 2 diabetes and obesity.
Taylor AM
Curr Diab Rep; 2008 Oct; 8(5):345-52. PubMed ID: 18778582
[TBL] [Abstract][Full Text] [Related]
15. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
[TBL] [Abstract][Full Text] [Related]
16. Insulin Resistance as Related to Psychiatric Disorders in Obese Children.
Özalp Kızılay D; Yalın Sapmaz Ş; Şen S; Özkan Y; Ersoy B
J Clin Res Pediatr Endocrinol; 2018 Nov; 10(4):364-372. PubMed ID: 29789273
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity.
Robinson LE; Graham TE
Can J Appl Physiol; 2004 Dec; 29(6):808-29. PubMed ID: 15630152
[TBL] [Abstract][Full Text] [Related]
18. Biology of metabolic syndrome in a vascular patient.
Vykoukal D; Davies MG
Vascular; 2012 Jun; 20(3):156-65. PubMed ID: 22700582
[TBL] [Abstract][Full Text] [Related]
19. Mediators of sympathetic activation in metabolic syndrome obesity.
Straznicky NE; Eikelis N; Lambert EA; Esler MD
Curr Hypertens Rep; 2008 Dec; 10(6):440-7. PubMed ID: 18959829
[TBL] [Abstract][Full Text] [Related]
20. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk.
Bergman RN; Kim SP; Hsu IR; Catalano KJ; Chiu JD; Kabir M; Richey JM; Ader M
Am J Med; 2007 Feb; 120(2 Suppl 1):S3-8; discussion S29-32. PubMed ID: 17296343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
